HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[The treatment of Parkinson's disease--adenosine A2A receptor antagonists].

Abstract
The primary pathology of Parkinson's disease is the degeneration of dopaminergic neurons in the nigrostriatal pathway, resulting in a significant reduction in striatum dopamine concentration which is responsible for the altered motor functions. With time and disease progression, efficacy of dopaminergic therapy becomes unpromising. Since adenosine A2A receptor is selectively localized in striatum for controlling motor activity, it appeared to be an attractive target for a novel treatment in Parkinson's disease. Several lines of evidence indicated that KW-6002, highly selective antagonist of adenosine A2A receptor, showed anti-parkinsonian effect in vivo and in vitro without any problematic side effect which is observed in dopaminergic therapy. Further investigation will be necessary to make sure the effect in ongoing progressive nature of Parkinson's disease or the long treatment periods in Parkinson's disease.
AuthorsEtsuro Matsubara, Mikio Shoji, Koji Abe
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 60 Issue 1 Pg. 112-6 (Jan 2002) ISSN: 0047-1852 [Print] Japan
PMID11808320 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Antiparkinson Agents
  • Purinergic P1 Receptor Antagonists
  • Purines
  • Receptor, Adenosine A2A
  • Receptors, Purinergic P1
  • Xanthines
  • KF 17837
  • istradefylline
  • Dopamine
Topics
  • Antiparkinson Agents (therapeutic use)
  • Corpus Striatum (metabolism)
  • Dopamine (metabolism)
  • Drug Design
  • Humans
  • Parkinson Disease (drug therapy, etiology, physiopathology)
  • Purinergic P1 Receptor Antagonists
  • Purines (pharmacology, therapeutic use)
  • Receptor, Adenosine A2A
  • Receptors, Purinergic P1 (metabolism)
  • Xanthines (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: